[Federal Register Volume 75, Number 109 (Tuesday, June 8, 2010)]
[Notices]
[Page 32506]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-13752]



-----------------------------------------------------------------------



DEPARTMENT OF JUSTICE



Drug Enforcement Administration




Manufacturer of Controlled Substances; Notice of Application



    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 

Regulations (CFR), this is notice that on April 12, 2010, Boehringer 

Ingelheim Chemicals Inc., 2820 N. Normandy Drive, Petersburg, Virginia 

23805-9372, made application by renewal to the Drug Enforcement 

Administration (DEA) to be registered as a bulk manufacturer of the 

basic classes of controlled substances listed in schedule II:



------------------------------------------------------------------------

                    Drug                               Schedule

------------------------------------------------------------------------

Amphetamine (1100).........................  II

Lisdexamfetamine (1205)....................  II

Methylphenidate (1724).....................  II

Methadone (9250)...........................  II

Methadone Intermediate (9254)..............  II

------------------------------------------------------------------------



    The company plans to manufacture the listed controlled substances 

in bulk for sale to its customers for formulation into finished 

pharmaceuticals.

    Any other such applicant, and any person who is presently 

registered with DEA to manufacture such substances, may file comments 

or objections to the issuance of the proposed registration pursuant to 

21 CFR 1301.33(a).

    Any such written comments or objections should be addressed, in 

quintuplicate, to the Drug Enforcement Administration, Office of 

Diversion Control, Federal Register Representative (ODL), 8701 

Morrissette Drive, Springfield, Virginia 22152; and must be filed no 

later than August 9, 2010.



     Dated: May 28, 2010.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug 

Enforcement Administration.

[FR Doc. 2010-13752 Filed 6-7-10; 8:45 am]

BILLING CODE 4410-09-P